Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rangering i aksjer #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Aksjekurs
$30.90
Markedsverdi
$1.90B
Endring (1 dag)
1.68%
Endring (1 år)
819.64%
Land
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategori

Pris DMRA pris med markedsverdi på B
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
DMRA
$30.90
Markedsverdi av Damora Therapeutics, Inc.(DMRA)
Markedsverdi: $1.90B
Per August 2026 har Damora Therapeutics, Inc. en markedsverdi på $1.90B. Dette gjør Damora Therapeutics, Inc. til det 6695th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Damora Therapeutics, Inc. fra 2020 til 2026
DMRA sammenlignet med topp 5 mest populære stocks
Pris på DMRA Eiendel B Markedsverdi for B Resultater
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$89,866.86 $1.90B
$5.532T +290,731.25%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$74,864.64 $1.90B
$4.608T +242,180.40%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$66,537.97 $1.90B
$4.096T +215,233.23%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$60,897.21 $1.90B
$3.748T +196,978.34%
Damora Therapeutics, Inc. Damora Therapeutics, Inc.
$44,861.21 $1.90B
$2.761T +145,081.90%